Thaçi, D., Vender, R., de Rie, M., Conrad, C., Soung, J., Strober, B., Wang, M., Cross, N., Deherder, D., Gomez, N.N. and Gottlieb, A.B. 2022. Bimekizumab efficacy and safety through three years in patients with moderate to severe plaque psoriasis: Long-term results from the BE SURE randomized controlled trial and the BE BRIGHT open-label extension. SKIN The Journal of Cutaneous Medicine. 6, 6 (Nov. 2022), s68. DOI:https://doi.org/10.25251/skin.6.supp.68.